SNORA71B and prostate cancer: Mechanistically, SNHG17 and its homolog SNORA71B were transactivated by signal transducer and activator of transcription 5A (STAT5A), and SNHG17 sponged with miR-339-5p and released the expression of STAT5A, thereby forming a regulatory loop and exacerbating prostate cancer progression [35].